Plasmacytoid dendritic cells and their therapeutic activity in cancer

34Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the last decade several studies provided evidence that plasmacytoid dendritic cells (pDCs) infiltrate human neoplasms with poor prognosis. However, the role of tumor-associated pDCs remains controversial. Various studies indicate that pDCs play an immuno-suppressive role and facilitate tumor progression in both animal models and humans. In contrast, others found that the presence of activated tumor-associated pDCs results in tumor regression in mice. Given these findings, understanding pDC function in tumor biology is an important necessity and may pave the way for novel therapeutic strategies to fight malignancies. © 2012 Landes Bioscience.

Cite

CITATION STYLE

APA

Pinto, A., Rega, A., Crother, T. R., & Sorrentino, R. (2012). Plasmacytoid dendritic cells and their therapeutic activity in cancer. OncoImmunology, 1(5), 726–734. https://doi.org/10.4161/onci.20171

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free